Matthew K. Szot, CFO, sold Cadrenal Therapeutics ($CVKD) shares on the open market 12 times over the past year for nearly $400,000, with his latest sale on December 29, 2025; this ranks 6,958th among nearly 12,000 insiders averaging $8.6 million per person across 6 sales each. He also sold tiny stakes in SenesTech ($SNES) for $2.75 on November 14, 2025 (11,626th rank) and INVO Fertility ($IVF) for $6.08 on December 3, 2025 (11,622nd rank). No open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 29, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | S | Common Stock | 9933 | $6.97 | 0.0000 | 2,044,033 | 100.00% | 0.49% |
| Dec. 4, 2025 | INVO Fertility, Inc. | $IVF | Szot Matthew K | Director | J | Common stock | 3 | $0.00 | 0.0000 | 15,130,282 | 100.00% | 0.00% |
| Dec. 3, 2025 | INVO Fertility, Inc. | $IVF | Szot Matthew K | Director | S | Common stock | 4 | $1.52 | 3.0000 | 15,130,282 | 57.14% | 0.00% |
| Nov. 14, 2025 | SenesTech, Inc. | $SNES | Szot Matthew K | Director | S | Common Stock | 1 | $2.75 | 0.0000 | 5,223,015 | 100.00% | 0.00% |
| Oct. 24, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1800 | $13.99 | 11,733.0000 | 2,044,033 | 13.30% | 0.09% |
| Oct. 27, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1800 | $13.99 | 9,933.0000 | 2,044,033 | 15.34% | 0.09% |
| Oct. 9, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1693 | $13.99 | 15,333.0000 | 2,044,033 | 9.94% | 0.08% |
| Oct. 13, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1800 | $14.07 | 13,533.0000 | 2,044,033 | 11.74% | 0.09% |
| Oct. 6, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | S | Common Stock | 107 | $13.99 | 17,026.0000 | 2,044,033 | 0.62% | 0.01% |
| Oct. 1, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1700 | $13.99 | 17,133.0000 | 2,044,033 | 9.03% | 0.08% |
| Sept. 29, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | S | Common Stock | 100 | $14.00 | 18,833.0000 | 1,961,642 | 0.53% | 0.01% |
| Sept. 24, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1500 | $14.00 | 29,833.0000 | 1,961,642 | 4.79% | 0.08% |
| Sept. 25, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | S | Common Stock | 10900 | $14.05 | 18,933.0000 | 1,961,642 | 36.54% | 0.56% |
| Aug. 28, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | S | Common Stock | 400 | $14.00 | 31,333.0000 | 1,961,642 | 1.26% | 0.02% |
| Aug. 27, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1600 | $14.00 | 31,733.0000 | 1,961,642 | 4.80% | 0.08% |
| Aug. 26, 2025 | INVO Fertility, Inc. | $IVF | Szot Matthew K | Director | A | Stock Option (right to buy) | 45000 | $0.00 | 45,164.0000 | 1,066,065 | 9999.99% | 4.22% |
| Jan. 23, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | A | Stock Options | 50000 | $0.00 | 50,000.0000 | 1,219,550 | 9999.99% | 4.10% |
| Aug. 27, 2024 | SenesTech, Inc. | $SNES | Szot Matthew K | Director | A | Stock Option (right to buy) | 12090 | $0.00 | 12,090.0000 | 515,340 | 9999.99% | 2.35% |
| Jan. 18, 2024 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | A | Stock Options | 250000 | $0.00 | 250,000.0000 | 899,465 | 9999.99% | 27.79% |
| June 26, 2023 | SenesTech, Inc. | $SNES | Szot Matthew K | Director | A | Stock Option (right to buy) | 39402 | $0.00 | 39,402.0000 | 6,748 | 9999.99% | 100.00% |
| May 18, 2023 | INVO Fertility, Inc. | $IVF | Szot Matthew K | Director | A | Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 24, 2023 | Cadrenal Therapeutics, Inc. | $CVKD | Szot Matthew K | Chief Financial Officer | A | Common Stock | 50000 | $0.00 | 500,000.0000 | 7,890,507 | 11.11% | 0.63% |